Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levodopa in Angelman Syndrome
NCT01281475Phase 3Completed
- Start
- Jan 2011
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Angelman syndrome (AS) comparing Levodopa with Placebo (2 arms). Primary endpoint: Bayley Cognitive Age Equivalent at 1 Year. Started Jan 2011; status: completed.
02
Drugs
levodopa
03
Conditions
Angelman syndrome (AS)
Beyond the preview
Go deeper on NCT01281475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01281475.